Cancer Breakthrough: 50-60% Success Rate, Cures the Incurable
May 21, 2011
Dr. Stanislaw Burzynski and his son, Dr. Gregory Burzynski, employ novel gene-target therapies in the treatment of cancer, which is the leading cause of death in the US.
Born in the early 1940's in Poland, Dr. Stanislaw Burzynski was trained as a biochemist and a physician, and has been developing a treatment called antineoplastons over the past 35 years. He's also the Founder, President and Chairman of the Burzynski Institute, located in both Houston, Texas, and Stafford.